Bob is a former director of the National Venture Capital Association and President of the New England Venture Capital Association. He has been recognized by the prestigious Forbes Midas List and AlwaysOn Venture Capital 100 as one of the top venture capitalists in the industry.
Before entering venture capital, he spent four years as the Executive Director of the John A. Hartford Foundation. He also was the Chief Executive of the Clark Foundation and the Burden Foundation. Bob is a former Assistant to the U.S. Secretary of Commerce and an Assistant to the head of the international division of the U.S. Treasury.
Bob graduated from Harvard College, and received his MBA from Harvard Business School. He has been a faculty member at the Harvard Business School since 2001. Also, he is a Fellow of the American Academy of Arts and Sciences and a Member of the Council on Foreign Relations.
Barbara is a Managing Director of Versant Ventures where she specializes in health services and health information technology. She leads Versant’s investments in Redbrick Health, Advanced ICU Care, Fidelis SeniorCare, and Vantage Oncology; her previous Versant investments include Cogent HealthCare, CodeRyte, and Titan HealthCare.
In her career as an operating executive and venture capital investor, Barbara led and advised provider, payer, and healthcare IT organizations throughout the US. Prior to co-founding Versant Ventures, she was a Partner at CrossPoint Venture Partners.
Barbara was formerly a division President at PacifiCare Health Systems, and was Senior VP at PHCS, a national PPO. Her operating career includes management roles at the hospital information systems division of Hewlett Packard and the Harvard Community Health Plan, where she managed one of the first U.S. electronic medical records installations. She holds a BS from Tufts University and a Masters in Health Policy and Management from Harvard University.
She is Vice Chairman of the California Health Care Foundation, member of the Leadership Council of the Harvard School of Public Health, and Founder of the Innovation Conference Series for Health Services and HCIT CEOs.
Roger focuses on investments in software and technology-enabled business services and currently serves on the boards of G5 Search Marketing, iPipeline and Vibes Media. Prior to helping found Volition Capital in 2010, Roger was a partner at Fidelity Ventures where he focused on early growth equity investments including GeoLearning (acquired by SumTotal). Roger was also a partner at Apax Partners, focused primarily on investments in enterprise software and technology-enabled services including Intralinks, Planview and RealPage. Before that, he worked for GE Capital and was a Vice President of GE Equity, where he played a key role in developing the technology group’s investment strategy for business-to-business electronic commerce. His investments at GE Equity included Commerce One, OpenSite Technologies, Proxicom and Multex. Earlier in his career, Roger worked in corporate finance at Chase Manhattan Bank, and spent six years at Arthur Andersen in accounting and corporate finance. Roger is a National Judge for the Ernst & Young Entrepreneur of the Year awards. He is a former board member of the Venture Investors Association of New York and currently serves on the Advisory Board of The Quebec City Conference.
Roger received a bachelor of science degree in accounting from Syracuse University in 1987 and an MBA from the Wharton School at the University of Pennsylvania in 1995.
Dr. Beth Seidenberg is a partner at Kleiner Perkins Caufield & Byers focused on life science investing. She works with entrepreneurs to develop companies with breakthrough technology for treating patients and improving health. Since joining KPCB in 2005, Beth has incubated five companies and serves on the board of directors of 3-V Biosciences, Armo Biosciences, Atara, Auxogyn, Breathe Technologies, Epizyme, iPierian, Redbrick Health and TESARO.
Before joining KPCB, Beth was senior vice president of development and chief medical officer of Amgen, Inc. Earlier in her career, she was a senior executive in research and development at Bristol-Myers Squibb Co. and Merck & Co., Inc. Under her leadership, 10 innovative products were developed and marketed globally and achieved more than 40 regulatory approvals. Beth received her B.S. degree from Barnard College and her M.D. from the University of Miami. She completed her post-graduate training at Johns Hopkins University, George Washington University and the National Institutes of Health.
Dan drives RedBrick's overall strategy and growth. Before joining RedBrick in 2011, Dan was president and CEO at Secure Computing, a $250M leader in enterprise security solutions, prior to it being acquired by McAfee where he served as EVP and General Manager of their $500M Network Security Business Unit. Prior to Secure Computing, Dan served as President and Chief Operating Officer at Stellent, a leading enterprise content management software company that grew revenues from $2M to $130M during his tenure before being acquired by Oracle, where he became Senior Vice President of Enterprise Content Management Products. Dan joined Stellent from Foglight Software, an innovator in e-commerce and application performance management where he headed marketing, product management, and business development. At Foglight, the company grew from a startup to a market player realizing customer adoption by many leading e-commerce companies prior to its acquisition by Quest Software.
Dan earned his Bachelor of Science degree in math and economics from the University of Minnesota. Dan is an avid runner, and enjoys many outdoor activities including tennis, golf, kayaking, fishing and boating. He spends most of his spare time with his wife and four kids coaching and watching them in baseball, hockey and gymnastics.
Rick is an operating partner at Advent International, a Boston-based private equity firm. He previously served as CEO at OptumHealth, a division of UnitedHealth Group, overseeing care delivery, population health management and consumer programs. While at United, he also led the company’s Medicare Advantage business, Medicaid and children’s health insurance subsidiary, and its Emerging Businesses Group. In addition, he has a diverse background in other payer, provider and integrated delivery system organizations.
Stephen is the President of athenahealth’s Enterprise Solutions Group, offering health system and physician practice automation through cloud-based services for revenue cycle, electronic health records, clinical integration and patient access. His previous experience includes roles as CEO of AMICAS, VitalWorks, and Datamedic, successful health information technology companies. He also served as Medical Director and Systems Development Director of Information Systems at Johns Hopkins Medical Institution.
Sven brings more than 35 years of accounting and financial experience to the RedBrick board. He has worked previously as a CPA, an investment banker, a CFO for public companies InStent and Digi International, and an independent director for multiple emerging-growth companies. In recent years, Wehrwein has been part of three successful IPOs, as audit committee chair, for Twin Cities-based companies Compellent Technologies, Proto Labs and SPS Commerce.
Sven is a graduate of Loyola University in Chicago, and has a Master’s Degree in management from the Sloan School of Management at MIT.
Highland Capital Partners (www.hcp.com) was founded with the mission of helping great people build great companies. Since its inception in 1988, the firm has taken a sector-focused approach to investing in exceptional communications, consumer, digital media, health care and information technology companies. With over $2.6 billion of committed capital, Highland has invested in and worked to create such firms as Ask Jeeves, Avid Technology, CheckFree, Conor Medsystems, EXACT Sciences, Lycos, MapQuest, Mitotix, Ocular Networks, Odyssey Health Care, Origin MedSystems, Renal Treatment Centers, Sybase, Telica, US Labs and VistaPrint.
Additional information for Versant Ventures can be found at www.versantventures.com.
Volition Capital (www.volitioncapital.com) is a growth equity firm that principally invests in high potential, founder-owned companies across different technology sectors. The firm specializes in partnering with founders to help them achieve their fullest aspirations for their business.
Since its founding in 1972, Kleiner Perkins Caufield & Byers (www.kpcb.com) has backed entrepreneurs in over 600 ventures, including AOL, Amazon.com, Citrix, Compaq Computer, Electronic Arts, Genentech, Genomic Health, Google, Intuit, Juniper Networks, Netscape, Lotus, Sun Microsystems, Symantec, Verisign and Xilinx. KPCB portfolio companies employ more than 250,000 people. More than 150 of the firm’s portfolio companies have gone public. Many other ventures have achieved success through mergers and acquisitions. The firm has offices in Menlo Park, California; Beijing, China; and Shanghai, China.
HLM Venture Partners (HLM) is a leading venture capital firm providing capital to emerging companies focused on health care service, health care information technology and medical devices. HLM has over $400 million of venture capital under management and works with the leading growth companies that are improving the quality of health care while reducing overall costs. HLM supports entrepreneurs as they turn innovative ideas into market-leading businesses, offering guidance on financial structuring, resource allocation and deployment, strategic planning, strategic introductions, and recruitment. HLM has offices in Boston, Massachusetts, and San Francisco, California. (www.hlmvp.com)